seqWell
Biotechnology · Health Care
$23.5Mtotal raised · 9 rounds on record
$960klatest round · Venture round · Sep 2026 · 2 mo ago
50+team · employees, estimated range
4cities with offices
Overview
SeqWell delivers true multiplexing NGS library prep solutions using stunningly simple workflows.
Funding and backers
Total raised
$23.5M
9 rounds on record
Latest round
$960k
Venture round · Sep 2026 · 2 mo ago
Team
51-200
employees, estimated range
The money's age
Fresh money
2 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 1
Raised a round Venture round $960k · SEC Form D
Jan 15, 2025
Raised a round Convertible Note $12k · SEC Form D
Sep 16, 2024
Raised a round Venture round $3.1M · SEC Form D
Sep 11, 2023
Raised a round Convertible Note $3.4k · SEC Form D
Sep 11, 2023
Raised a round Venture round $3.4M · SEC Form D
Mar 23, 2022
Raised a round Venture round $7M · SEC Form D
Dec 19, 2019
Raised a round Venture round $7M · SEC Form D
Apr 27, 2017
Raised a round Venture round $700k · SEC Form D
Jun 16, 2016
Raised a round Venture round $1.3M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2026 | $960k | — | SEC Form D |
| Convertible Note | Jan 2025 | $12k | — | SEC Form D |
| Venture round | Sep 2024 | $3.1M | — | SEC Form D |
| Convertible Note | Sep 2023 | $3.4k | — | SEC Form D |
| Venture round | Sep 2023 | $3.4M | — | SEC Form D |
| Venture round | Mar 2022 | $7M | — | SEC Form D |
| Venture round | Dec 2019 | $7M | — | SEC Form D |
| Venture round | Apr 2017 | $700k | — | SEC Form D |
| Venture round | Jun 2016 | $1.3M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | seqWell Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Daniel CalvoExecutive Officer, DirectorSEC Form D
Joseph MellorExecutive Officer, DirectorSEC Form D
Thomas GrantExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

ゲノム ( DNA )、エピゲノム、トランスクリプトーム ( RNA )を独自の技術で解析し、研究開発の効率・精度を格段に向上させます。次世代シーケンス( NGS )/ エピジェネティクス 研究の 実験デザイン から 情報 解析、論文化、事業化までオーダーメイドで支援します。.

Learn howCanal's TrueLink® NGS technology safeguards your template without the need for end repair.

ChromaCode is a leading provider of HDPCR™ multiplexing technology for genomic solutions. Our breakthrough platform enables labs…

Reduce expert workload per NGS case by up to 85%. Qnomx leverages AI to streamline NGS interpretation and generate clinician-ready reports.

Basepair offers advanced NGS data analysis platform for academic, commercial, and clinical research. Try it today!

The majority of molecules sequenced are uninformative. Jumpcode Genomics is changing that by helping researchers boost usable NGS data.
Visa sponsorship
0
H-1B filings in 12 months
0
Open roles in United States
In the register as seqWell, Inc., Beverly, MA
Other sponsors in the same field
Alert me
US Department of Labor · latest filing Feb 19, 2025 · Visa details by country
Financials
Total raised
$23.5M
Latest round
Venture - Series Unknown
Funding rounds
9
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $960k | Details |
| Convertible Note | 2025 | $12k | Details |
| Venture - Series Unknown | 2024 | $3.1M | Details |
| Convertible Note | 2023 | $3.4k | Details |
| Venture - Series Unknown | 2023 | $3.4M | Details |
| Venture - Series Unknown | 2022 | $7M | Details |
| Venture - Series Unknown | 2019 | $7M | Details |
| Venture - Series Unknown | 2017 | $700k | Details |
| Venture - Series Unknown | 2016 | $1.3M | Details |
People

Daniel Calvo
Executive Officer, Director

Joseph Mellor
Executive Officer, Director

Thomas Grant
Executive Officer

Michael Finney
Director

Paul McEwan
Director

Chad Souvignier
Director

Amy Liao
Director

Anup Parikh
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
4
Hiring now
0
Countries
2
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Beverly
United States
HQ
Office Address
Beverly, MA 01915
Singapore
Singapore
Regional office
Southeast Asia – Vietnam, Thailand, Indonesia, Malaysia, Philippines, Singapore
#06-03 C, Singapore 556741
Cambridge
United States
Regional office
United Kingdom







Admera Health
Integrated DNA Technologies
GeneDx
Nephrogen